Immunotherapy with GD2 specific monoclonal antibodies.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use* / Q000633:toxicity; D000920:Antibody-Dependent Cell Cytotoxicity; D005732:Gangliosides / Q000276:immunology*; D006801:Humans; D007167:Immunotherapy; D009447:Neuroblastoma / Q000628:therapy*
D000911:Antibodies, Monoclonal; D005732:Gangliosides; C019403:ganglioside, GD2